EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Long‐term outcome of high‐grade encapsulated papillary carcinoma of the breast: implications for staging and management

Milena Stevanovic, Emad Rakha, Ian O. Ellis, Umberto Maccio, Bärbel Papassotiropoulos, Hisham Fansa, Lidija Stevanovic, Heike Frauchiger‐Heuer, Isabell Witzel, Zsuzsanna Varga

Histopathology · 2026-12 · 89 (6) · 941-953

DOI: 10.1111/his.70240 ↗
AbstractBibliografische Angaben

Abstract

Background Encapsulated papillary carcinoma (EPC) of the breast is an uncommon tumour with controversial biological behaviour and staging. Emerging evidence suggests that EPC with adverse pathological features (EPC‐A) may exhibit invasive potential. The absence of uniform staging criteria contributes to management variability. This study evaluates the clinicopathological characteristics and clinical course of high‐grade EPC (HG‐EPC), including EPC‐A. Materials and methods This retrospective multicentre study (2000–2025) included 25 HG‐EPC cases, irrespectively of ER/PR and HER2 status. Tumours with frank stromal invasion beyond microinvasive foci were excluded. Histopathological re‐evaluation was performed in accordance with 2019 WHO classification criteria. Results Of 38 cases reviewed, 25 fulfilled the inclusion criteria as EPC (mean age 57.2 years, mean tumour size 2.9 cm). Six cases (24%) demonstrated conventional‐type microinvasive components. A subset of 16 cases fulfilled criteria for EPC‐A, defined by high‐grade morphology in combination with ER/PR‐negative (or ER

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →